UK Knowledge Quarter welcomes Boehringer Ingelheim AI accele...
Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.
Newsletters and Deep Dive digital magazine
Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.
Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.
Protocol documentation will become protocol ingestion – an approach that’s automated, consistent, and intelligent.
In this week's second AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, named after UK scientist Rosalind Franklin.
In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.
Editor's Picks
Newsletters and Deep Dive
digital magazine